“…Approximately 70% of the patients with SCLC already have metastasis at diagnosis. Despite being a common and aggressive tumor with a tendency to metastasize, breast involvement is surprisingly rare [ [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] ]. The prognosis is abysmal whether one or both breasts are involved by SCLC, with an estimated five-year survival of only 2% [ 13 ].…”